Aze Wilson

<i>HLADQA1*05</i> genotype predicts anti‐drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease

Aze Wilson, Celeste Peel, Qian Wang et al. · Alimentary Pharmacology & Therapeutics · 2019 · 95 citations

Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease

Aze Wilson, Wendy A. Teft, Bridget L. Morse et al. · Digestive Diseases and Sciences · 2015 · 91 citations

Inflammation, Anti-inflammatory, Medicine +9

Identification and Characterization of Trimethylamine-<i>N</i>-oxide Uptake and Efflux Transporters

Wendy A. Teft, Bridget L. Morse, Brenda F. Leake et al. · Molecular Pharmaceutics · 2016 · 72 citations · Full text

Engineering, Tmao Exposure, Chemistry +16

<scp>HLA</scp>‐<scp>DQA</scp>1‐<scp>HLA</scp>‐<scp>DRB</scp>1 polymorphism is a major predictor of azathioprine‐induced pancreatitis in patients with inflammatory bowel disease

Aze Wilson, L. E. Jansen, Rhiannon V. Rose et al. · Alimentary Pharmacology & Therapeutics · 2017 · 70 citations · Full text

Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease

Aze Wilson, Ahmed A. Almousa, Wendy A. Teft et al. · Scientific Reports · 2020 · 63 citations · Full text